![Cyrus Harmon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cyrus Harmon
Gründer bei
OLEMA PHARMACEUTICALS, INC.
Vermögen: 7 Mio $ am 30.09.2026
Profil
Dr. Cyrus L.
Harmon is a President & Chief Executive Officer at Vilya, Inc. and an Independent Director at Olema Pharmaceuticals, Inc. He is on the Board of Directors at Olema Pharmaceuticals, Inc. Dr. Harmon was previously employed as a General Manager by Affymetrix, Inc. and a Chief Executive Officer by Neomorphics, Inc. He received his undergraduate degree from the University of California, Berkeley and a doctorate degree from the University of California, Berkeley.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 24.07.2026 | 819.798 ( 0,94 % ) | 7 Mio $ | 30.09.2026 |
Aktive Positionen von Cyrus Harmon
| Unternehmen | Position | Beginn |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Gründer | 07.08.2006 |
Vilya Inc.
 Vilya Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines to precise disease biology | Vorstandsvorsitzender | 01.10.2023 |
Ehemalige bekannte Positionen von Cyrus Harmon
| Unternehmen | Position | Ende |
|---|---|---|
| AFFYMETRIX, INC. | Corporate Officer/Principal | 01.01.2002 |
Neomorphics, Inc.
 Neomorphics, Inc. Medical SpecialtiesHealth Technology Develops, analyzes, and manages genetic information to improve disease | Vorstandsvorsitzender | 01.01.2000 |
Ausbildung von Cyrus Harmon
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
53
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells products and services for genetic analysis | Health Technology |
Neomorphics, Inc.
Neomorphics, Inc. Medical SpecialtiesHealth Technology Develops, analyzes, and manages genetic information to improve disease | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
 Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Vilya Inc.
Vilya Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines to precise disease biology | Health Technology |
